Tate & Lyle and APC Microbiome Ireland Apply for Synbiotic Fiber Application Patent

Tate & Lyle PLC, in partnership with APC Microbiome Ireland, a Science Foundation Ireland (SFI) Research Center, published its jointly filed international patent application for a synbiotic fiber technology that has shown positive preliminary results in metabolic health.

The technology uses a new combination of a probiotic, Lactobacillus mucosae, and soluble dietary fibers which could lead to a number of positive metabolic health changes including in heart health, weight management, liver health, potentially improving immunity, lowering inflammation markers, and improving gut health.

Dr Kavita Karnik, Global Head, Nutrition & Regulatory Affairs at Tate & Lyle, said: “We are delighted, following our initial two-year research project with APC Microbiome, to have our joint patent application published for this ingredient technology that uses our PROMITOR fiber. The health benefits this new synbiotic fiber ingredient could bring, such as improving heart health and tackling obesity, are exciting and another step on our journey to live our purpose of Transforming Lives through the Science of Food.